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Follicular lymphoma (FL) is the second most frequent
type of non-Hodgkin’s lymphoma. The follicular growth
pattern, cellular protein expression, such as CD10 and
BCL6, and the accumulation of ongoing somatic hyper-
mutation (SHM) within the immunoglobulin heavy (IgH)
chain gene variable regions (IgVH) in FL indicate that the
disease is a malignancy of germinal center B cells (1–3).
The characteristic with FL is the t(14;18)(q32;q21) chro-
mosomal translocation, which juxtaposes the BCL2 gene
on chromosome 18 with the IgH on chromosome 14 and
results in the dysregulation of the BCL2 (4–6). The molec-
ular anatomy around the t(14;18) breakpoints indicated
that the translocation occurs as an error of the D-JH
rearrangement at the pro-B cell stage of ontogeny (7, 8).
The inappropriate expression of BCL2 alone seems to
be insufﬁcient for malignant transformation of B cells
and multistep process is required for FL development (2,
3). Several studies in FL cases based on idiotype expres-
sion and SHM analysis within the IgVH have indicated
that t(14;18)-bearing B cells can migrate from bone mar-
row (BM) to germinal center of lymph node (LN) and
be clonally expanded after antigenic selection (9–14).
However, clonality analysis as to the immunoglobulin
light (IgL) chain was reported in a limited case (15).
Here we report a FL case in which LN and BM tumor
cells expressed different IgL chains. The results of molec-
ular analysis indicated that the two cell subpopulations
were derived from the common FL progenitor and devel-
oped into independent clones at different sites.
Patient and methods
Case report
A 51-yr-old woman was referred because of systemic
lymphadenopathy. An inguinal LN biopsy was consistent
with a FL, grade 2, according to the World Health
Organization classiﬁcation (1). Her BM biopsy sample
presented the inﬁltration of FL.
The result of karyotypic analysis on LN cells was
as follows: 51,XX,+2,add(7)(q32),+12,t(14;18)(q32;q21),
+17,+21,+mar[3⁄4]⁄46,XX[1⁄4]. Interphase ﬂuorescent
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juxtaposition of the BCL2 with the IgH on 30% of cells
analyzed.
Flow cytometry
Cells obtained from LN and BM were analyzed by two-
color immunoﬂuorescence with a ﬂow cytometer (FAC-
SCalibur; Becton Dickinson, Mountain View, CA, USA)
for expression of surface antigens. Analyses were done
using monoclonal antibodies speciﬁc for CD3, CD5,
CD10 and CD19 (Beckman Coulter, Miami, FD, USA);
CD20 (Dako, Glostrup, Denmark); Igj and k chain (BD
Biosciences, San Jose, CA, USA). Immunoreactivity was
evaluated on CD45-gated cell populations.
DNA isolation and Southern blotting
Genomic DNA was extracted from biopsied LN cells and
BM mononuclear cells. DNA was also prepared from the
patient’s peripheral blood mononuclear cells, in which no
lymphoma cells were detected. An informed consent was
obtained in accordance with the Declaration of Helsinki.
After DNA digestion with HindIII (for the IgH), BamHI
(for the Igj) and EcoRI plus HindIII (for the Igk), South-
ern blotting was carried out by standard procedure.
Probes were ﬂuorescein-labeled using Gene Images
Random Prime Labeling kit (GE Healthcare, Bucking-
hamshire, UK) and hybridization signals were detected
using Gene Images CDP-star Detection kit (GE Health-
care). DNA probes for detection of the IgH, the Igj and
the Igk gene rearrangement were as follows: JH, a 3.5-kb
EcoRI-HindIII fragment; Cj, a 2.5-kb EcoRI fragment;
Ck, a 0.7-kb BglII-EcoRI fragment containing the Ck3.
PCR and DNA sequence
The DNA was ampliﬁed by PCR using LA Taq Poly-
merase (Takara Bio, Otsu, Japan) for the BCL2⁄IgH
rearrangement and the IgH gene analysis. The cycling
conditions included an initial denaturation for 4 min at
94 C followed by 30 cycles of with 94 C denaturing for
30 s and 6 to 8 min annealing⁄primer extension at 68 C
plus ﬁnal extension 7 min at 72 C. Reaction mixture
(50 lL) contained 100–200 ng DNA in LA-PCR reaction
buffer with 0.4 lmol⁄L primers, 0.4 mmol⁄L dNTPs,
2.5 mmol⁄L MgCl2, and 2.5U LA Taq-Polymerase. The
PCR products were directly cloned into pCR2.1-TOPO
vector (Invitrogen, San Diego, CA, USA) and sequenced
by an ABI Prism 310 Genetic Analyzer (Applied Bio-
systems, Foster City, CA, USA).
For detection of the Igj deleting element (Kde) rear-
rangement, DNA was also ampliﬁed employing PCR sys-
tem and primers previously reported by Stolz et al. (16).
PCR primers for the BCL2⁄IgH rearrangement and the
IgH gene analysis
For detection of the BCL2⁄IgH rearrangement, several
previously reported sets of forward BCL2 and reverse IgH
primers (17) were used for screening. For cloning of the
chromosomal breakpoint, a new BCL2 forward primer,
5¢-CAGATGAGCATGAATGGTACTGTACCG-3¢, for
3¢ region of the major breakpoint region (MBR) and IgH
reverse primer (Sl), 5¢-ACATAAATGAGTCTCCTGCT-
CTTCATCAAG-3¢, for switching l region were
employed. Additional reverse primers, 3¢JH, 5¢-CCCA-
CAGGCAGTAGCAGAAAACAA-3¢ and 5¢JH, 5¢-ATG-
GCAGAATGTCCATCCTCACCCCAC-3¢ were used for
further analysis.
For analysis of SHM, DNA was ampliﬁed using for-
ward VH family-speciﬁc leader primers in conjunction
with a reverse consensus JH primer as previously
reported (18). A 5¢ upstream primer within the VH3-53
(5¢VH3-53, 5¢-GTCGTGTCTGATGAAGTCACACAC-
TCAGAC-3¢) was prepared on the basis of published
sequence. For ampliﬁcation of germline VH3-53,3 ¢VH3-
53 primer (5¢-CTGATAGGAGGAGACTCAGCAGG-3¢),
which annealed to the sequence 380 bp downstream from
the 3¢ heptamer nonamer recombination sequences, was
also employed. The locations of primers used in this
study were shown in Figs 2 and 3.
Results
Flow cytometry analysis revealed that LN and BM
tumor cells presented an inverse pattern in surface IgL
chain expression; Igj)k+ in LN and Igj+k) in BM
(Fig. 1A). The expressions of other surface antigens were
similar in both samples (positive for CD10, CD19 and
CD20, and negative for CD3 and CD5). Southern blot-
ting presented monoclonal Ig rearrangements in both
samples, but rearranged IgL gene was different between
the two; the Igk in LN and the Igj in BM (Fig. 1B). In
analysis of Kde conﬁguration, Vj1-Kde and Vj3-Kde
recombinations were detected in LN, while only Vj3-
Kde was detected in BM (Fig. 1C). Sequence around the
Vj3-Kde recombination junction was identical in both
samples (data not shown).
On PCR screening using the previously reported primer
sets (17), the chromosome 18 breakpoint was predicted to
be located out of MBR in both LN and BM. A set of
new BCL2 and IgH-Sl primers ampliﬁed a 5.9-kb DNA
fragment from LN and a 5.4-kb one from BM, respec-
tively (Fig. 2). Sequence analysis revealed an identical
BCL2-JH5 recombination junction on both samples (data
not shown), with the chromosome 18 breakpoint located
at 5 kb downstream of the MBR (Fig. 2A). However,
525 bp deletion within JH region on chromosome 14 had
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Figure 1 (A) Flow cytometric analysis of
surface Igj and Igk chain expression on the
patient’s LN and BM cells. (B) Southern blot
analysis presenting Ig gene rearrangements.
Lanes C present the germ line control.
Arrows show the rearrange bands. (C) PCR
detection of the Kde rearrangement. DNA
was ampliﬁed by primer sets as indicated.
Arrows show the ampliﬁed fragments with
size. Lanes C present DNA from the patient’s
peripheral blood mononuclear cells.
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Figure 2 (A) Structure of the der(14)
chromosome generated by t(14;18)(q32;q21)
translocation. Vertical arrows show the
chromosomal breakpoints. Deleted region in
BM cells is shown by a dashed line. Open
boxes are exons. Horizontal arrows indicate
the locations of PCR primers. E, EcoRI; H,
HindIII. (B) PCR detection of the BCL2-IgH
fusion on der(14). DNA was ampliﬁed by
primer sets as indicated. Arrows show the
ampliﬁed fragments with size. Lanes C
present DNA from the patient’s peripheral
blood mononuclear cells.
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tional JH primers (Fig. 2B).
On Southern blotting, two rearrange bands were
hybridized with JH probe in both LN and BM samples
(Fig. 1B). Among these bands, the size of smaller bands
(5.1 kb in LN and 4.6 kb in BM) coincided with the
length of the cloned HindIII fragments containing the
BCL2-JH junction (Fig. 2A). Thus, these bands were
considered to be generated by t(14;18) translocation, with
the difference in length due to the deletion in BM.
On the other hand, the comigrating 7.6 kb bands
seemed to represent the variable, diversity and joining
segments (VDJ) recombination on the untranslocated
IgH allele. On PCR screening using VH leader primers
(18), a set of VH3-speciﬁc primer and a JH primer
ampliﬁed the rearranged fragment from both samples
and the sequence of the 5¢ part of ampliﬁed fragments
showed the greatest homology with the VH3-53
sequence. Then, DNA from tumor cells was subjected to
ampliﬁcation employing the 5¢ VH3-53 forward primer
and Sl reverse primer (Fig. 3A). As shown in Fig. 3B,
8.3 kb bands were obtained from both samples by this
primer set, which were ascertained as having VH3-53
region by partial sequence analysis. The cloned PCR
products contained the HindIII fragments corresponding
to the bands on Southern blotting.
To characterize the SHM patterns in LN and BM, 10
sequences from independent bacterial isolates in each
sample were analyzed in comparison with the germline.
As shown in Fig. 4, base replacements were classiﬁed
into three forms; common to both clones, LN or BM
clone-speciﬁc and intraclonal sporadic ones. Germline
sequence obtained from the patient’s peripheral blood
mononuclear cells (analyzed on 10 bacterial isolates) was
completely identical to the published one. When a clone-
speciﬁc mutation was deﬁned as one observed in more
than 90% of bacterial isolates from a cell subpopulation,
among the 293 nucleotides from FR1 to CDR3 region
within the VH3-53, 12 (4.1%), 26 (8.9%) and 12 (4.1%)
mutations were common to both, LN-speciﬁc and BM-
speciﬁc, respectively.
Discussion
Here we presented a FL case presenting the difference in
IgL chain expression between the LN and BM tumor
cells. The results of immunophenotypic and genetic stud-
ies coincided and conﬁrmed that Igj)k+ cells in LN
and Igj+k) cells in BM represented separate clones in
the immunological viewpoint. These two tumor clones
shared an identical BCL2-IgH recombination, accompa-
nying t(14;18)(q32;q21) translocation, and an identical
VDJ joining on the untranslocated IgH allele. In the Igj
gene analysis, these clones also shared an identical Vj3-
Kde recombination, but a fertile rearrangement involving
Cj was detected only in BM on Southern blotting and
LN cells seemed to have biallelic abortive Vj-Kde
recombinations followed by the Igk rearrangement.
These observations indicated that the two clones were
derived from the common progenitor cells at the stage
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Figure 3 (A) Structure of the VH3-53 region
and the VDJ recombination on the untrans-
located IgH allele. Horizontal arrows indicate
the locations of PCR primers. H, HindIII. (B)
PCR detection of the VDJ recombination and
germ line VH3-53 region. DNA was ampliﬁed
by primer sets as indicated. Lanes C present
DNA from the patient’s peripheral blood
mononuclear cells as germ line control.
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ontogeny, which harbored t(14;18) translocation.
Kobrin et al. (15) reported a FL case in which IgL
expression of tumor cells changed from Igj at diagnosis
to Igk at relapse and raised the possibility that
Igk-expressing cells would have arisen subsequent to a
secondary IgL rearrangement that occurred in Igj-
expressing tumor cells, as SHMs were shared by both
cell subpopulations. In our case, it is not likely that
Igk-expressing LN cells were converted from Igj-
expressing BM cells, as the concomitant IgH deletion
on the der(14) chromosome in BM, which seemed to
occur subsequent to the generation of the t(14;18) trans-
location, was not present in LN. On the other hand,
results of the Igj gene analysis including the Kde rear-
rangement indicated that Igj-expressing BM cells would
not be derived from Igk-expressing LN cells. Thus, in
this case, two tumor clones seemed to have developed
independently, rather than that one had been converted
from the other.
The SHM analysis within the IgVH revealed the
occurrence of LN- and BM-speciﬁc base replacements.
In the previous report on the SHM analysis in BM-inﬁl-
trated FL cases (19), it was shown that the majority of
BM tumor cells were derivatives of ‘LN-inexperienced’
clone. Clone-speciﬁc SHMs in LN and BM in our case
also indicate that these two clones were transformed by
antigenic selection independently at the two sites.
However, some of base replacements within the IgVH
observed in this case were common to the both clones
and seemed to be tumor-related SHMs that generated at
an early stage of development, as polymorphisms were
denied by germline sequence from the patient’s non-lym-
phoma cells. As SHM is generally regarded as properties
exhibited in mature B cells (20), the shared SHM pat-
terns in this case would indicate that the common pro-
genitor cells had reached at GC stage, and then
developed into LN and BM tumor cells with indepen-
dently occurring secondary IgL rearrangements (receptor
revisions).
Figure 4 Nucleotide sequence comparison within the VH3-53 region in LN and BM tumor cells. The nucleotide sequences obtained from bacte-
rial isolates are compared with germline (GL) sequence from the patient’s peripheral blood mononuclear cells. Identity with GL is shown by
dashes, replacement mutations are shown by uppercase letters and silent mutations are shown lowercase letters.
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taking SHM as reported in cases with acute lymphoblas-
tic leukemia L2 with t(14;18) (21), it would be probable
that LN and BM tumor clones were originated from the
common progenitor at the pre-B cell stage and developed
with shared and clone-speciﬁc SHMs. It is unknown
whether or not the occurrence of SHMs in early B cell
stage was the feature with t(14;18)-bearing cells. Further
investigation is needed to clarify this point.
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